Eschenbachia blinii
Eschenbachia blinii
Eschenbachia blinii is a plant species that has not been traditionally used in any known medical or cultural practices. The scientific community has primarily focused on its genetic structure, with studies such as sequencing the complete plastid genome of Erigeron breviscapus and analyzing the chloroplast genome of Dichrocephala benthamii contributing to our understanding of its genetic makeup within the tribe Astereae. Additionally, research has identified CbMYB108 as a transcription factor that positively regulates diterpene synthesis and capitate glandular trichome density in E. blinii. Ferrous iron was found to increase capitate glandular trichome density and blinin content, dependent on the expression of CbHO-1. No significant safety concerns or recorded drug interactions have been identified for this plant species as of current research findings.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The complete plastid genome of Erigeron breviscapus was sequenced, providing genetic information without specific health claims.
- The study sequenced and analyzed the chloroplast genome of Dichrocephala benthamii, revealing its structure and contributing to its genetic understanding within tribe Astereae.
- CbMYB108 was identified as a transcription factor that positively regulates both diterpene synthesis and capitate glandular trichome density in C. blinii.
- Ferrous iron increased capitate glandular trichome density and blinin content in Conyza blinii, dependent on CbHO-1 expression.
- UV-B exposure increased blinin content in Conyza blinii by enhancing antioxidant activities and upregulating transporter genes, without significantly inhibiting growth.
Frequently asked questions
What is Eschenbachia blinii?
Eschenbachia blinii (Eschenbachia blinii) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Eschenbachia blinii?
5 sourced findings are recorded for Eschenbachia blinii; the strongest carries evidence grade D. For example: The complete plastid genome of Erigeron breviscapus was sequenced, providing genetic information without specific health claims.
How strong is the evidence for Eschenbachia blinii?
The strongest finding for Eschenbachia blinii carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Eschenbachia blinii safe? What are the side effects?
No major safety issues are recorded for Eschenbachia blinii in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Eschenbachia blinii interact with medications?
No drug interactions are recorded for Eschenbachia blinii in our sources. This does not rule them out — check with a pharmacist.
Is Eschenbachia blinii a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Ferrous iron-induced increases in capitate glandular trichome density and upregulation of CbHO-1 contributes to increases in blinin content in Conyza blinii. literature abstract metadata
- T2 Enhanced antioxidant capacity and upregulated transporter genes contribute to the UV-B-induced increase in blinin in Conyza blinii. literature abstract metadata
- T2 Complete plastid genome sequence of Erigeron breviscapus (Asteraceae), an endemic traditional Chinese herbal medicine. literature abstract metadata
- T2 CbMYB108 integrates the regulation of diterpene biosynthesis and trichome development in Conyza blinii against UV-B. literature abstract metadata
- T2 Phylogenomic Analysis of Dichrocephala benthamii and Comparative Analysis within Tribe Astereae (Asteraceae). literature abstract metadata